In June 2026, the 28th China International Beauty & Cosmetics Expo (CBE) grandly opened in Shanghai. Weptide Biotechnology, an ODM/OEM enterprise focused on functional skin care and medical device sectors, made a stunning appearance with its core product matrix and innovative solutions.
Cosmetic-Device Integration, Full-Process Innovative Solutions
At this exhibition, Weptide Biotechnology highlighted its "Cosmetic-Device Integration" innovative model—deeply integrating Class II medical device safety standards with cosmetic efficacy experiences, providing brand owners with full-process services from formula development, registration and filing to finished product manufacturing. This model effectively solves the balance challenge between efficacy claim compliance and product experience for brand owners.
Core Ingredient Technology Highlights
At the booth, the Recombinant Humanized Type III Collagen series became the center of attention. This technology adopts a genetic engineering expression system, with product purity ≥95% and amino acid sequences fully identical to human collagen, exhibiting excellent biocompatibility. Combined with synergistic formulas of active ingredients such as Sodium Hyaluronate and peptides, it covers multiple efficacy scenarios including repair, anti-aging, and moisturizing.
Full-Chain Delivery Capability
Weptide Biotechnology owns four production bases, covering a total area of over 100,000m², equipped with 6 automated production lines, with a daily production capacity of 6 million units (bottles/sheets). Backed by 100+ Class II medical device certificates, the GMPC+ISO dual certification system, and 72 patented technologies, the company has built a complete delivery capability from raw materials to finished products.
Full-Process Service Capability
From needs communication, formula development, sample confirmation, to mass production, quality inspection, and final delivery, Weptide Biotechnology provides end-to-end full-process services. Brand owners need not worry about the trivial details of the production process—our full-process services allow brands to focus on market expansion and sales, leaving production matters to us.
On-Site Signing Boom at the Exhibition
During the exhibition, Weptide Biotechnology reached strategic partnerships with multiple brands, creating a lively on-site signing atmosphere. Brands such as Baiyunshan have established deep cooperative relationships, with cumulative services provided to over 800 brands.
Four Production Bases
Weptide Biotechnology has established four production bases nationwide, forming a production capacity network covering South and Central China:
- Guangzhou Weptide Factory: No. 77, Group 15, Dalang Village, Baiyunhu Street, Baiyun District, Guangzhou City
- Guangdong Weptide Factory: No. 18, Taoyuan East Road, Songgang Songxia Industrial Park, Shishan Town, Nanhai District, Foshan City
- Guangdong Jinan Gene Factory: Factory Building No. 23, Hongguang Industrial Park, No. 2 Wende Fifth Street, Zhaoqing High-tech Zone, Zhaoqing City, Guangdong Province
- Hunan Weptide Factory: Room 501, Building 11, Lanyue Valley Intelligent Industrial Park, Xieyuan North Road, Ningxiang Economic Development Zone, Changsha City, Hunan Province
